These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7128666)
21. Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans. Almeida L; Soares-da-Silva P J Clin Pharmacol; 2004 Aug; 44(8):906-18. PubMed ID: 15286095 [TBL] [Abstract][Full Text] [Related]
22. Gas chromatographic assay for oxcarbazepine and its main metabolites in plasma. von Unruh GE; Paar WD J Chromatogr; 1985 Nov; 345(1):67-76. PubMed ID: 4086590 [TBL] [Abstract][Full Text] [Related]
23. Protein binding of oxcarbazepine and its primary active metabolite, 10-hydroxycarbazepine, in patients with trigeminal neuralgia. Patsalos PN; Elyas AA; Zakrzewska JM Eur J Clin Pharmacol; 1990; 39(4):413-5. PubMed ID: 2076729 [TBL] [Abstract][Full Text] [Related]
24. The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine. van Heiningen PN; Eve MD; Oosterhuis B; Jonkman JH; de Bruin H; Hulsman JA; Richens A; Jensen PK Clin Pharmacol Ther; 1991 Oct; 50(4):410-9. PubMed ID: 1914377 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique. Fortuna A; Alves G; Falcão A; Soares-da-Silva P Epilepsia; 2012 Mar; 53(3):529-38. PubMed ID: 22372629 [TBL] [Abstract][Full Text] [Related]
26. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers. Antunes Nde J; Wichert-Ana L; Coelho EB; Della Pasqua O; Alexandre Junior V; Takayanagui OM; Tozatto E; Marques MP; Lanchote VL Eur J Clin Pharmacol; 2016 Feb; 72(2):195-201. PubMed ID: 26514967 [TBL] [Abstract][Full Text] [Related]
27. Liquid chromatographic analysis of oxcarbazepine and its metabolites in plasma and saliva after a novel microextraction by packed sorbent procedure. Saracino MA; Tallarico K; Raggi MA Anal Chim Acta; 2010 Feb; 661(2):222-8. PubMed ID: 20113739 [TBL] [Abstract][Full Text] [Related]
28. Use of saliva for monitoring oxcarbazepine therapy in epileptic patients. Klitgaard NA; Kristensen O Eur J Clin Pharmacol; 1986; 31(1):91-4. PubMed ID: 3780834 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models. Fortuna A; Alves G; Soares-da-Silva P; Falcão A Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973 [TBL] [Abstract][Full Text] [Related]
30. Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humans. Almeida L; Soares-da-Silva P Drugs R D; 2003; 4(5):269-84. PubMed ID: 12952496 [TBL] [Abstract][Full Text] [Related]
31. In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein. Zhang C; Zuo Z; Kwan P; Baum L Epilepsia; 2011 Oct; 52(10):1894-904. PubMed ID: 21692796 [TBL] [Abstract][Full Text] [Related]
32. Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta. Myllynen P; Pienimäki P; Raunio H; Vähäkangas K Hum Exp Toxicol; 1998 Dec; 17(12):668-76. PubMed ID: 9988371 [TBL] [Abstract][Full Text] [Related]
33. In vivo exposure of marine mussels to carbamazepine and 10-hydroxy-10,11-dihydro-carbamazepine: Bioconcentration and metabolization. Boillot C; Martinez Bueno MJ; Munaron D; Le Dreau M; Mathieu O; David A; Fenet H; Casellas C; Gomez E Sci Total Environ; 2015 Nov; 532():564-70. PubMed ID: 26102056 [TBL] [Abstract][Full Text] [Related]
34. Transplacental passage of oxcarbazepine and its metabolites in vivo. Myllynen P; Pienimäki P; Jouppila P; Vähäkangas K Epilepsia; 2001 Nov; 42(11):1482-5. PubMed ID: 11879354 [TBL] [Abstract][Full Text] [Related]
35. A novel enantioselective microassay for the high-performance liquid chromatography determination of oxcarbazepine and its active metabolite monohydroxycarbazepine in human plasma. Mazzucchelli I; Franco V; Fattore C; Marchiselli R; Perucca E; Gatti G Ther Drug Monit; 2007 Jun; 29(3):319-24. PubMed ID: 17529889 [TBL] [Abstract][Full Text] [Related]
36. Oxcarbazepine: preliminary clinical and pharmacokinetic studies on a new anticonvulsant. Hooper WD; Dickinson RG; Dunstan PR; Pendlebury SC; Eadie MJ Clin Exp Neurol; 1987; 24():105-12. PubMed ID: 3268334 [TBL] [Abstract][Full Text] [Related]
37. High-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification of carbamazepine, oxcarbazepine, and their main metabolites in human serum. Lionetto L; Casolla B; Cavallari M; Tisei P; Buttinelli C; Simmaco M Ther Drug Monit; 2012 Feb; 34(1):53-8. PubMed ID: 22210100 [TBL] [Abstract][Full Text] [Related]
38. Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma. Fortuna A; Sousa J; Alves G; Falcão A; Soares-da-Silva P Anal Bioanal Chem; 2010 Jun; 397(4):1605-15. PubMed ID: 20401721 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic drug interactions in children taking oxcarbazepine. Sallas WM; Milosavljev S; D'souza J; Hossain M Clin Pharmacol Ther; 2003 Aug; 74(2):138-49. PubMed ID: 12891224 [TBL] [Abstract][Full Text] [Related]
40. Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites. Mogensen PH; Jórgensen L; Boas J; Dam M; Vesterager A; Flesch G; Jensen PK Acta Neurol Scand; 1992 Jan; 85(1):14-7. PubMed ID: 1546529 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]